キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/12/19 | 3,465 | 3,545 | 3,465 | 3,510 | ±0 | ±0% | 47,600 |
2024/12/18 | 3,525 | 3,530 | 3,480 | 3,510 | -10 | -0.3% | 53,300 |
2024/12/17 | 3,530 | 3,565 | 3,500 | 3,520 | -10 | -0.3% | 45,700 |
2024/12/16 | 3,545 | 3,555 | 3,510 | 3,530 | -15 | -0.4% | 42,600 |
2024/12/13 | 3,575 | 3,600 | 3,515 | 3,545 | -55 | -1.5% | 82,600 |
2024/12/12 | 3,605 | 3,625 | 3,570 | 3,600 | +25 | +0.7% | 70,800 |
2024/12/11 | 3,580 | 3,605 | 3,570 | 3,575 | +5 | +0.1% | 47,500 |
2024/12/10 | 3,600 | 3,605 | 3,565 | 3,570 | -5 | -0.1% | 47,400 |
2024/12/09 | 3,555 | 3,600 | 3,555 | 3,575 | +10 | +0.3% | 41,000 |
2024/12/06 | 3,610 | 3,625 | 3,550 | 3,565 | -45 | -1.2% | 54,600 |
2024/12/05 | 3,675 | 3,680 | 3,610 | 3,610 | -65 | -1.8% | 50,500 |
2024/12/04 | 3,700 | 3,715 | 3,660 | 3,675 | -50 | -1.3% | 48,900 |
2024/12/03 | 3,675 | 3,760 | 3,675 | 3,725 | +25 | +0.7% | 71,800 |
2024/12/02 | 3,635 | 3,730 | 3,635 | 3,700 | +55 | +1.5% | 81,900 |
2024/11/29 | 3,640 | 3,670 | 3,605 | 3,645 | +35 | +1% | 45,900 |
2024/11/28 | 3,590 | 3,630 | 3,545 | 3,610 | -20 | -0.6% | 58,400 |
2024/11/27 | 3,670 | 3,670 | 3,580 | 3,630 | -55 | -1.5% | 48,700 |
2024/11/26 | 3,655 | 3,685 | 3,620 | 3,685 | +85 | +2.4% | 54,500 |
2024/11/25 | 3,695 | 3,725 | 3,545 | 3,600 | -55 | -1.5% | 167,700 |
2024/11/22 | 3,680 | 3,725 | 3,625 | 3,655 | -35 | -0.9% | 48,300 |
2024/11/21 | 3,700 | 3,730 | 3,670 | 3,690 | -15 | -0.4% | 36,900 |
2024/11/20 | 3,625 | 3,705 | 3,625 | 3,705 | +80 | +2.2% | 45,700 |
2024/11/19 | 3,645 | 3,675 | 3,615 | 3,625 | ±0 | ±0% | 37,100 |
2024/11/18 | 3,580 | 3,650 | 3,540 | 3,625 | -25 | -0.7% | 62,300 |
2024/11/15 | 3,710 | 3,710 | 3,640 | 3,650 | -40 | -1.1% | 32,900 |
2024/11/14 | 3,700 | 3,740 | 3,680 | 3,690 | -25 | -0.7% | 38,100 |
2024/11/13 | 3,710 | 3,740 | 3,690 | 3,715 | +20 | +0.5% | 54,100 |
2024/11/12 | 3,680 | 3,730 | 3,680 | 3,695 | +45 | +1.2% | 53,300 |
2024/11/11 | 3,640 | 3,670 | 3,605 | 3,650 | -10 | -0.3% | 77,100 |
2024/11/08 | 3,685 | 3,715 | 3,610 | 3,660 | -30 | -0.8% | 78,200 |
2024/11/07 | 3,710 | 3,770 | 3,670 | 3,690 | +5 | +0.1% | 121,500 |
2024/11/06 | 3,780 | 3,810 | 3,650 | 3,685 | -95 | -2.5% | 141,600 |
2024/11/05 | 3,715 | 3,780 | 3,690 | 3,780 | +30 | +0.8% | 66,100 |
2024/11/01 | 3,700 | 3,790 | 3,695 | 3,750 | +10 | +0.3% | 48,700 |
2024/10/31 | 3,740 | 3,770 | 3,700 | 3,740 | +25 | +0.7% | 78,900 |
2024/10/30 | 3,705 | 3,740 | 3,690 | 3,715 | +15 | +0.4% | 105,800 |
2024/10/29 | 3,670 | 3,715 | 3,660 | 3,700 | -5 | -0.1% | 43,400 |
2024/10/28 | 3,670 | 3,725 | 3,665 | 3,705 | +20 | +0.5% | 46,200 |
2024/10/25 | 3,750 | 3,760 | 3,675 | 3,685 | -65 | -1.7% | 47,500 |
2024/10/24 | 3,740 | 3,760 | 3,705 | 3,750 | -5 | -0.1% | 62,300 |
2024/10/23 | 3,780 | 3,820 | 3,755 | 3,755 | -25 | -0.7% | 52,700 |
2024/10/22 | 3,830 | 3,830 | 3,775 | 3,780 | -55 | -1.4% | 54,000 |
2024/10/21 | 3,850 | 3,865 | 3,830 | 3,835 | -15 | -0.4% | 59,200 |
2024/10/18 | 3,850 | 3,910 | 3,850 | 3,850 | +35 | +0.9% | 71,700 |
2024/10/17 | 3,790 | 3,830 | 3,790 | 3,815 | +30 | +0.8% | 56,600 |
2024/10/16 | 3,755 | 3,830 | 3,755 | 3,785 | +5 | +0.1% | 54,000 |
2024/10/15 | 3,785 | 3,810 | 3,770 | 3,780 | +20 | +0.5% | 57,800 |
2024/10/11 | 3,720 | 3,760 | 3,710 | 3,760 | +10 | +0.3% | 75,700 |
2024/10/10 | 3,725 | 3,750 | 3,715 | 3,750 | +25 | +0.7% | 69,600 |
2024/10/09 | 3,700 | 3,730 | 3,675 | 3,725 | +25 | +0.7% | 71,800 |
101~
150
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サワイGHD | 188,900円 | +5.9% | +24.5% | 2.91% | 12.53倍 | 1.18倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム